Literature DB >> 25456160

The chemokine receptor CXCR6 controls the functional topography of interleukin-22 producing intestinal innate lymphoid cells.

Naoko Satoh-Takayama1, Nicolas Serafini2, Thomas Verrier2, Abdessalem Rekiki2, Jean-Christophe Renauld3, Gad Frankel4, James P Di Santo5.   

Abstract

Interleukin-22 (IL-22) plays a critical role in mucosal defense, although the molecular mechanisms that ensure IL-22 tissue distribution remain poorly understood. We show that the CXCL16-CXCR6 chemokine-chemokine receptor axis regulated group 3 innate lymphoid cell (ILC3) diversity and function. CXCL16 was constitutively expressed by CX3CR1(+) intestinal dendritic cells (DCs) and coexpressed with IL-23 after Citrobacter rodentium infection. Intestinal ILC3s expressed CXCR6 and its ablation generated a selective loss of the NKp46(+) ILC3 subset, a depletion of intestinal IL-22, and the inability to control C. rodentium infection. CD4(+) ILC3s were unaffected by CXCR6 deficiency and remained clustered within lymphoid follicles. In contrast, the lamina propria of Cxcr6(-/-) mice was devoid of ILC3s. The loss of ILC3-dependent IL-22 epithelial stimulation reduced antimicrobial peptide expression that explained the sensitivity of Cxcr6(-/-) mice to C. rodentium. Our results delineate a critical CXCL16-CXCR6 crosstalk that coordinates the intestinal topography of IL-22 secretion required for mucosal defense.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25456160     DOI: 10.1016/j.immuni.2014.10.007

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  79 in total

Review 1.  Diversity and function of group 1 innate lymphoid cells.

Authors:  Victor S Cortez; Marco Colonna
Journal:  Immunol Lett       Date:  2016-07-06       Impact factor: 3.685

2.  Selectivity in the Use of Gi/o Proteins Is Determined by the DRF Motif in CXCR6 and Is Cell-Type Specific.

Authors:  Satya P Singh; John F Foley; Hongwei H Zhang; Darrell E Hurt; Jennifer L Richards; Craig S Smith; Fang Liao; Joshua M Farber
Journal:  Mol Pharmacol       Date:  2015-08-27       Impact factor: 4.436

3.  Spatial distribution of LTi-like cells in intestinal mucosa regulates type 3 innate immunity.

Authors:  Cristiane Sécca; Jennifer K Bando; José L Fachi; Susan Gilfillan; Vincent Peng; Blanda Di Luccia; Marina Cella; Keely G McDonald; Rodney D Newberry; Marco Colonna
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

4.  The brave new world of innate lymphoid cells.

Authors:  Gérard Eberl; James P Di Santo; Eric Vivier
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

Review 5.  The balance of power: innate lymphoid cells in tissue inflammation and repair.

Authors:  Jim G Castellanos; Randy S Longman
Journal:  J Clin Invest       Date:  2019-06-10       Impact factor: 14.808

Review 6.  Neuroimmune regulation during intestinal development and homeostasis.

Authors:  Henrique Veiga-Fernandes; Vassilis Pachnis
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

Review 7.  RORγt, a multitask nuclear receptor at mucosal surfaces.

Authors:  G Eberl
Journal:  Mucosal Immunol       Date:  2016-10-05       Impact factor: 7.313

8.  Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.

Authors:  Tingting Ju; Yasmeen Shoblak; Yanhua Gao; Kaiyuan Yang; Janelle Fouhse; B Brett Finlay; Yee Wing So; Paul Stothard; Benjamin P Willing
Journal:  Appl Environ Microbiol       Date:  2017-08-17       Impact factor: 4.792

Review 9.  Regulation of inflammation by microbiota interactions with the host.

Authors:  J Magarian Blander; Randy S Longman; Iliyan D Iliev; Gregory F Sonnenberg; David Artis
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

10.  NKR-P1B expression in gut-associated innate lymphoid cells is required for the control of gastrointestinal tract infections.

Authors:  Elias Abou-Samra; Zachary Hickey; Oscar A Aguilar; Michal Scur; Ahmad Bakur Mahmoud; Sergey Pyatibrat; Megan M Tu; Jeffrey Francispillai; Arthur Mortha; James R Carlyle; Mir Munir A Rahim; Andrew P Makrigiannis
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.